Reimbursements Clause Example with 25 Variations from Business Contracts
This page contains Reimbursements clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 Exhibit 10.17 ULTHERA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee mem...bers of the board of directors (the "Board") of Ulthera, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing of the initial public offering of Company common stock (the "Effective Date").View More
Variations of a "Reimbursements" Clause from Business Contracts
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.6 16 d63338dex106.htm EX-10.6 EX-10.6 Exhibit 10.17 ULTHERA, 10.6 PHATHOM PHARMAC...EUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM PROGRAM* Non-employee members of the board of directors (the "Board") of Ulthera, Phathom Pharmaceuticals, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2019 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the Effective Date. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.4 8 d14529dex104.htm EX-10.4 EX-10.4 Exhibit 10.17 ULTHERA, 10.4 PROMETHEUS BIOSC...IENCES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Prometheus Biosciences, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2021 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the effective date of the Equity Plan (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.6 9 d63338dex106.htm EX-10.6 EX-10.6 Exhibit 10.17 ULTHERA, 10.6 PHATHOM PHARMACE...UTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Phathom Pharmaceuticals, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2019 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the Effective Date. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.4 6 d897644dex104.htm EX-10.4 EX-10.4 Exhibit 10.17 ULTHERA, 10.4 AVIDITY BIOSCIE...NCES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Avidity Biosciences, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2020 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the effective date of the Equity Plan (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.7 10 d690055dex107.htm EX-10.7 EX-10.7 Exhibit 10.17 ULTHERA, 10.7 GOSSAMER BIO, ...INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Gossamer Bio, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2019 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the Effective Date. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. Capitalized terms not otherwise defined herein shall have the meanings ascribed in the Equity Plan. All share numbers in this Program shall become effective on give effect to the date of reverse stock split to be effected by the closing of the Company in connection with its initial public offering of Company common stock (the "Effective Date"). offering. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.11 14 d588296dex1011.htm EX-10.11 EX-10.11 Exhibit 10.17 ULTHERA, 10.11 CRINETICS... PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Crinetics Pharmaceuticals, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2018 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the Effective Date. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 EX-10.7 11 d662886dex1017.htm EX-10.17 EX-10.17 d626950dex107.htm EX-10.7 EX-10.7 Exhibit 10.17 ULTHERA, 10.7 GOSSAMER BIO, INC.... NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Gossamer Bio, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2019 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the Effective Date. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.1 2 d881251dex101.htm EX-10.1 EX-10.1 Exhibit 10.17 ULTHERA, 10.1 SYNLOGIC, INC. ...AMENDED & RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM As of December 2019 Non-employee members of the board of directors (the "Board") of Ulthera, Synlogic, Inc. (formerly known as Mirna Therapeutics, Inc.) (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Amended & Restated Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. December 13, 2017. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time time, without advance notice, in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing of the initial public offering of Company common stock December 13, 2017 (the "Effective Date"). View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 2 EX-10.3 5 rlyp-ex103_20150331537.htm EX-10.3 Exhibit 10.17 ULTHERA, 10.3 RELYPSA, INC.... NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Relypsa, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being was adopted pursuant to the Board's resolutions on June 6, 2013, and amended pursuant to the Board's resolutions on March 13, 2014, and further amended pursuant to the Board's resolutions on April 25, 2014. 13, 2015. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become became effective on the date of the closing of the initial public offering of Company common stock (the "Effective Date"). stock. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.1 2 ardx-20190331ex101320fc2.htm EX-10.1 ardx_Ex10_1 Exhibit 10.17 ULTHERA, 10.1 ...ARDELYX, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Ardelyx, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being was adopted pursuant to the Board's resolutions on April 25, 2014. May 23, 2014, and amended pursuant to the Board's resolutions on March 3, 2017 and March 14, 2019. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing of the initial public offering of Company common stock (the "Effective Date"). View More
